Back to search

University of Thessaly (UTH)

Αξιολόγηση δραστικότητας νανοσωματιδίων έναντι πολυανθεκτικών βακτηρίων

Abstract

dc:description

The increasing frequency of multidrug resistant bacterial infections in nosocomial settings is widely recognized as one of the most urgent public health problems. The main directions to compact the dire consequences of the multidrug resistance threat are: a) the multifaceted containment of the spreading of multidrug resistant (MDR) strains and b) the development of new therapeutic approaches. Among the latter, the use of cyclodextrin based nanocarriers has been proposed for the targeted carrying of antibiotic substances at the site of infection (improving their pharmacokinetic properties) as well as for their protection from antimicrobial resistance mechanisms. Furthermore, modified and antibiotic free nanoparticles could be used either as direct antimicrobial agents or as indirect inhibitors of important resistance mechanisms. In this study, we examined natural and modified nanoparticles and cyclodextrins for their properties either as carriers of clinically available antimicrobial agents, as direct antimicrobial compounds or as indirect ones, exerting inhibitory properties against the main antimicrobial resistance mechanisms. The positively charged octacis (6-(2-aminomethyl)-6-deoxy)-γ-cyclodextrin (γ-Cys), produced by N.C.S.R. Demokritos, in preliminary studies was shown to produce strong complexes with the penicillin oxacillin, protecting it from the carbapenamase Oxa-1, reducing the hydrolysis rate in photometric studies. In-vitro, the γ-Cys cyclodextrin presented a desirable toxicological profile, as it did not exhibit signs of cytotoxicity even in high concentrations. Lastly, we determined its ability to enter in macrophages, carrying its antimicrobial load and significantly increasing its intracellular concentration. We also examined modified cyclodextrins for their applications as inhibitors against resistant mechanisms such as efflux pumps and MBLs. The AMBnTßCD cyclodextrins, produced by Innovative Biologics (U.S.A.), are modified with 7 positive charged subunits (7+ß-CD) and were studied as inhibitors for the RND efflux systems, produced by clinical strains of Α. baumannii. In in-vitro studies, they successfully re-sensitized clinical strains producing such efflux systems in the antibiotics tetracycline and ciprofloxacin. Their re-sensitizing properties were proven both in MIC determination studies and in time-kill assays. In these assays the bacterial load was reduced by at least 1,5 log10 in the presence of nanomolar concentrations of the AMBnTßCD compared to the free antibiotic, at the end of a 24 hour incubation. The modified cyclodextrins, produced by N.C.S.R. Demokritos, exhibited significant synergy with newer b-lactams in in-vitro, ex-vivo and in-vivo studies, against MDR Gram-negative clinical strains.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Miliotis, Georgios
  • Μηλιώτης, Γεώργιος

Subjects

dc:subject × 18

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45784

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Miliotis, Georgios; Μηλιώτης, Γεώργιος. Αξιολόγηση δραστικότητας νανοσωματιδίων έναντι πολυανθεκτικών βακτηρίων. University of Thessaly (UTH), 2019. http://hdl.handle.net/10442/hedi/45784